Since my previous coverage, the stock has gained about 1.75%, underperforming the S&P 500 by about 3%. In this updated article, I am empirically estimating the price target for 2027. Technical ...
Pantelis Samartsidis, Claudia R. Eickhoff, Simon B. Eickhoff, Tor D. Wager, Lisa Feldman Barrett, Shir Atzil, Timothy D. Johnson, Thomas E. Nichols Journal of the ...
Objective To perform a large-scale pairwise and network meta-analysis on the effects of all relevant exercise training modes on resting blood pressure to establish optimal antihypertensive exercise ...
Meta-analysis is an objective examination of published data from many studies of the same research topic identified through a literature search. Through the use of rigorous statistical methods, it can ...
Background The role of mineralocorticoid receptor antagonists (MRAs) in acute myocardial infarction (MI) remains ...
The study addresses a critical clinical question, as patients with type 2 diabetes mellitus (T2DM) face a substantially ...
Addition of Navitoclax to Ongoing Ruxolitinib Therapy for Patients With Myelofibrosis With Progression or Suboptimal Response: Phase II Safety and Efficacy We identified published studies from 1983 to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback